- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-06-0019411

Nephron Pharmaceuticals Private Limited
About Nephron Pharmaceuticals Private Limited
Data last updated:
Nephron Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U51909UR2021PTC013129. Its GSTIN is 05AAHCN8912G1ZF (Uttarakhand).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.43 Cr. It is led by directors including Shadab Ansari and Seema Khan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Khasra No. 754 Village Sirchandi Pargana Bhagwanpur Tehsil Bhagwanpur, Haridwar, Uttarakhand, India – 247661.
As per MCA filings, the company has open charges of ₹9.64 Cr on record.
Nephron Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0019411).
Company details
Recognitions & Rankings of Nephron Pharmaceuticals
Contact details
Nephron Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhasra No. 754 Village Sirchandi Pargana Bhagwanpur Tehsil Bhagwanpur, Haridwar, Uttarakhand, India – 247661
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nephron Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nephron Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nephron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nephron Pharmaceuticals Private Limited
Nephron Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhurendra Kumar | Additional Director | 27 Nov 2025 | 0 Years 11 Months | Current |
| Shadab Ansari | Director | 26 Oct 2021 | 5 Years 0 Months | Current |
| Seema Khan | Director | 26 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Nephron Pharmaceuticals Private Limited is audited by SANJAY DHINGRA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY DHINGRA & ASSOCIATES | FY 2022 | 511011C |
Shareholding
The shareholding of Nephron Pharmaceuticals Private Limited is on record for FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nephron Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2023 | 100830339 | State Bank of India | ₹9.64 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nephron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nephron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nephron Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Nephron Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCN8912G1ZF | Uttarakhand | Active | 10 Feb 2022 |
To see the full GST registrations and return filing status of Nephron Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nephron Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Madhurendra Kumar was appointed as Additional Director on 27 Nov 2025.
Frequently asked questions
Nephron Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2021 (5+ years old) and is registered under CIN U51909UR2021PTC013129.
Nephron Pharmaceuticals has 3 current directors:
- Madhurendra Kumar - Additional Director
- Shadab Ansari - Director
- Seema Khan - Director
The latest financial statements of Nephron Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Nephron Pharmaceuticals is 05AAHCN8912G1ZF, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Nephron Pharmaceuticals is U51909UR2021PTC013129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nephron Pharmaceuticals was incorporated on 26 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Madhurendra Kumar was appointed as Additional Director on 27 Nov 2025. Seema Khan was appointed as Director on 26 Oct 2021. Shadab Ansari was appointed as Director on 26 Oct 2021.
Yes, Nephron Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0019411).
The registered office of Nephron Pharmaceuticals is at Khasra No. 754 Village Sirchandi Pargana Bhagwanpur Tehsil Bhagwanpur, Haridwar, Uttarakhand, India – 247661.
Nephron Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.